220 Cost per response for abatacept versus adalimumab in patients with seropositive erosive, early rheumatoid arthritis in the United States, Germany, Spain and Canada. (25th April 2018)

Record Type:: Journal Article
Title:: 220 Cost per response for abatacept versus adalimumab in patients with seropositive erosive, early rheumatoid arthritis in the United States, Germany, Spain and Canada. (25th April 2018)
Main Title:: 220 Cost per response for abatacept versus adalimumab in patients with seropositive erosive, early rheumatoid arthritis in the United States, Germany, Spain and Canada
Authors:: Foo, Jason
Rodríguez-Heredia, José M R
Polanco Sánchez, Carlos
Mtibaa, Mondher
Herrmann, Kirsten H
Alemao, Evo
Postema, Roelien
Baerwald, Christoph
Abstract:
Is Part Of:: Rheumatology. Volume 57(2018)Supplement 3
Journal:: Rheumatology
Issue:: Volume 57(2018)Supplement 3
Issue Display:: Volume 57, Issue 3 (2018)
Year:: 2018
Volume:: 57
Issue:: 3
Issue Sort Value:: 2018-0057-0003-0000
Page Start:
Page End:
Publication Date:: 2018-04-25
Subjects:: Rheumatism -- Periodicals
Rheumatology -- Periodicals
616.723005
Journal URLs:: http://rheumatology.oupjournals.org ↗
http://rheumatology.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://firstsearch.oclc.org ↗
DOI:: 10.1093/rheumatology/key075.444 ↗
Languages:: English
ISSNs:: 1462-0324
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 7960.731900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 16527.xml